Home › Funds › Northern Trust Corp › BCLI
Northern Trust Corp position in BCLI
BRAINSTORM CELL THERAPEUTICS
Latest position (Q3 2024)112.36K sh
Reported value held$25.88K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 59.09K | $195.00K | New |
| Q4 2021 | 59.09K | $236.00K | Hold |
| Q1 2022 | 55.92K | $188.00K | Reduce |
| Q2 2022 | 55.92K | $154.00K | Hold |
| Q3 2022 | 55.92K | $247.00K | Hold |
| Q4 2022 | 55.92K | $91.70K | Hold |
| Q1 2023 | 55.92K | $184.52K | Hold |
| Q2 2023 | 54.79K | $112.86K | Reduce |
| Q3 2023 | 54.79K | $10.96K | Hold |
| Q4 2023 | 54.79K | $14.96K | Hold |
| Q1 2024 | 54.79K | $30.94K | Hold |
| Q2 2024 | 112.36K | $38.03K | Add |
| Q3 2024 | 112.36K | $25.88K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.